Cat | Cas | Eng
Previous issues
Digital newsletter of IDIBELL
Number 135 - 19 February 2015

New neurotransmission regulators involved in the pathogenesis of neurological diseases

The ionotropic glutamate receptors play many roles in the physiological functioning of synapses, and their deregulation is associated with multiple neuropathological conditions. More and more there are evidences that the subclasses of these receptors (NMDA, AMPA or Kainat) are dynamic structures that move between the cytosol and the neuronal membrane, where they act as calcium channels. This has opened new avenues of research that aim to explain how and why these receptors reach the synaptic membrane or drop out.

[+ info]
COMBACTE-MAGNET, an European project to promote the development of antibiotics in Europe

34 European academic partners and 5 pharmaceutical companies are launching a new project, COMBACTE-MAGNET, under the IMI AMR research programme New Drugs 4 Bad Bugs (ND4BB). ND4BB has been launched to stimulate antibiotic development in Europe. COMBACTE-MAGNET (Combating Bacterial Resistance in Europe - Molecules against Gram-Negative Infections) will bring highly innovative studies and activities related to prevention and treatment of infections caused by multi-drug resistant Gram-negative bacteria (MDR-GNB). 

[+ info]
The AECC awarded two IDIBELL research projects during the Solidarity Night

The Spanish Association against Cancer (AECC) awarded on 5 February five aids on cancer research during the celebration of the third edition of the Solidarity Night organized annually by the entity. Two of these projects have been awarded to researchers IDIBELL: Alberto Villanueva, head of the group of chemoresistance and predictors of tumor response and a half stromal environment ICO-IDIBELL and Sonia Guil, researcher at Epigenetics and Cancer Biology research group at IDIBELL.

[+ info]
Previous news
Ramón Areces Foundation funds an IDIBELL project on hereditary blindness
Catalan Health Department promotes healthy habits to reduce cancer risk
Epigenetics for all audiences
Discovered a possible new therapeutic strategy against a very aggressive infant bone cancer
The IDIAP Jordi Gol and the IDIBELL seek common research projects
Carolina Garcia-Vidal, 2015 ESCMID Young Investigator Award for Research in Clinical Microbiology and Infectious Diseases
Manel Esteller wins the first edition of 'El Llobregat' Awards
New animal models faithfully reproduce the tumor of each patient
Events and meetings
Specialseminar. Laura M. Lechuga: “Nanophotonic lab-on-chip biosensors for advanced diagnostics”
IDIBELL Seminars. Andrea Alimonti: “A non-cell-autonomous mechanism controlling senescence evasion and chemoresistance in tumors”
El Periódico de Catalunya - Esperança en mans de joves científics
Televisió de l'Hospitalet - Dos projectes IDIBELL becats per l'AECC
El Mundo - La sala de máquinas del genoma
Communication Department
Institut d'Investigació Biom├Ędica de Bellvitge
93 260 71 29
93 260 72 82
Follow us:
Share with a friend:
By e-mail

Legal notice | Contact